3881 results for «2020»
3881 results
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
Innovations in heart failure: moving the heart forward
13 May 2024 – From EuroPCR 2024
Is this patient a good candidate for Left Atrial Appendage Closure? An interactive rapid-fire discussion
16 May 2024 – From EuroPCR 2024
This interactive session focuses on selecting good candidates for left atrial appendage (LAA) closure procedures. It covers the key clinical elements driving the indication for LAA closure and the technical elements that make a case complex. Through a series of case presentations and discussions, the session...
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
Valve-in-valve: utility of splitting devices
15 May 2024 – From EuroPCR 2024
This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
State-of-the-art on left main interventions in Latin America
16 May 2024 – From EuroPCR 2024
This session, in collaboration with the Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI), provides insights into the management of left main coronary artery disease in Latin America. Attendees will learn about the revascularization guidelines for left main in the region, the approaches to left main bifurcations...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Coronary issues before, during and after TAVI
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging clinical cases highlighting the complex interplay between coronary artery disease and transcatheter aortic valve implantation (TAVI). Attendees will witness real-world scenarios, including high-risk PCI with concomitant severe aortic stenosis, the management of degenerated aortic bioprostheses with the risk of...
Other coronary interventions: SSO2, angioPy & more
16 May 2024 – From EuroPCR 2024
This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....
Percutaneous tricuspid treatment in challenging anatomies
16 May 2024 – From EuroPCR 2024
Watch this session on percutaneous tricuspid treatment to explore key cases, including managing tricuspid valve-in-valve implantation in a patient with a giant right atrium, transcatheter edge-to-edge repair post-Mustard procedure, and tricuspid replacement in a challenging extreme anatomy case. You'll also learn about cross-caval treatment for torrential...
TAVI updates: expanding indications
14 May 2024 – From EuroPCR 2024
This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...
Acute coronary syndrome caused by coronary aneurysms
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.
CTO within a bifurcation
16 May 2024 – From EuroPCR 2024
This session will present various cases of chronic total occlusions (CTOs) within a bifurcation. Participants will learn about the challenges, diagnostic techniques, and treatment strategies for these complex cases, including the use of IVUS, CT angiography, and the hybrid algorithm for successful CTO interventions.
ANOCA/INOCA: when angiography is not enough to reach a diagnosis
16 May 2024 – From EuroPCR 2024
This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...
PCR's Got Talent - Round 2 - Session 2
15 May 2024 – From EuroPCR 2024
This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).
PCR's Got Talent - Round 2 - Session 1
15 May 2024 – From EuroPCR 2024
LoDoCo2 - Low-dose colchicine in coronary disease
02 Sep 2020
Reported from ESC Congress 2020 - Massimo Imazio (Turin, Italy) discusses with Dejan Milasinovic the results of the LoDoCo2 trial which showed that Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease.
Author
STS/ACC TVT Registry: Cerebral embolic protection and TAVR outcomes
19 Oct 2020
At TCT Connect 2020, David J. Cohen (Kansas City, Missouri, USA) presented results from an analysis of the TVT registry focusing on impact of Cerebral Embolic Protection (CEP) on TAVR outcomes. Nicolas Dumonteil provides a summary of the key messages.
Author
COMPARE CRUSH: A randomized trial of prehospital crushed vs uncrushed prasugrel in STEMI
20 Oct 2020
Luis Ortega-Paz provides a summary of the key messages from the COMPARE CRUSH trial. He also discusses the main findings and recommendations in clinical practice with Georgios Vlachojannis who presented the results during TCT Connect 2020.
Author
